The UIW's Feik School of Pharmacy achieved the highest pharmacy licensure exam pass rate in Texas, while the Class of 2025 ...

FirstWord Pharma’s 2026 list aggregates core pipeline assets from the world’s leading pharmaceutical companies. Alongside ivonescimab, the list highlights transformative therapies such as Eli Lilly’s ...

CHICAGO, Jan. 28, 2026 (GLOBE NEWSWIRE) -- COUR Pharma, a clinical-stage biotechnology company developing first-in-class, antigen-specific immune tolerance therapies for autoimmune diseases, announced ...

Denifanstat (ASC40), a once-daily oral fatty acid synthase (FASN) inhibitor, demonstrated favorable safety and tolerability in a Phase III open-label study - The ...

NMD Pharma is accelerating ignaseclant’s clinical development in CMT alongside multiple near-term clinical catalysts across its neuromuscular pipeline, with Phase 2 studies in spinal muscular atrophy ...

In a worrying indication of regulatory violations in the medical devices sector, the Drugs Control Administration (DCA), ...

Cory Doctorow and Tim Wu explain why the internet failed to live up to its early promise.

Driven by unhealthy diets, sedentary lifestyles, growing consumption of ultra-processed foods (UPFs), the latest Economic Survey (2025-26) flagged that obesity is fuelling a surge in NCDs such as ...

Total net revenue of $15.2 million Adjusted EBITDA1 of $ (0.8) million, which includes EXXUA launch investments $30.0 million cash balance at December 31, 2025 Company launched EXXUA™ (gepirone) ...

India, Jan. 24 -- With cancer incidence rising globally, several Indian pharmaceutical companies are strengthening their presence in oncology. Stocks such as Sun Pharma, Dr Reddy's, Cipla, Glenmark, ...

Solutions exist to control the rising costs of pharmaceuticals in employee-funded health insurance plans, but long-entrenched ...

Novel TL1A/IL23p19 bispecific antibody targets drivers of disease pathogenesis to overcome the efficacy ceiling in ...